Big announcement

1. BYD sold 201,493 new energy vehicles in January, up 33.14% year on year

$BYD COMPANY (01211.HK)$The Hong Kong Stock Exchange announced the January 2024 automobile production and sales report. The company produced 205,588 new energy vehicles in January, 154,188 units in the same period last year, up 33.34% year on year; sales of new energy vehicles in January were 201,493 units, compared with 151,341 units in the same period last year, up 33.14% year on year.

2. Ideal Auto: A total of 31,165 new cars were delivered in January, an increase of 105.8% over the previous year

$LI AUTO-W (02015.HK)$According to the Hong Kong Stock Exchange, a total of 31,165 new vehicles were delivered in January 2024, an increase of 105.8% over the previous year. Since delivery, the cumulative number of Ideal Cars delivered has reached 664,529 units. As of January 31, 2024, Ideal Auto has 474 retail centers across the country, covering 142 cities.

3. NIO delivered 1,055 vehicles in January, a year-on-year increase of 18.2%

$NIO-SW (09866.HK)$According to the January 2024 delivery data, the company delivered 10,055 new vehicles in January, up 18.2% year on year and down 44.2% month on month; as of January 31, 2024, NIO's cumulative delivery volume reached 459,649 vehicles.

4. Xiaopeng Motor delivered 8,250 smart electric vehicles in January, a year-on-year increase of 58%

$XPENG-W (09868.HK)$It was announced that in January 2024, Xiaopeng Motor delivered a total of 8,250 smart electric vehicles, an increase of 58% over the previous year. At the beginning of January 2024, Xiaopeng Motor launched the Xiaopeng X9 Super Smart Driving large seven-seater MPV and immediately began delivery in more than 100 cities in China. In January 2024, the company delivered a total of 2,478 Xiaopeng X9s, of which orders for the Xiaopeng X9Max model accounted for about 70% of the total Xiaopeng X9 orders.

5. Conet Optics Yingxi: Net profit is expected to increase by no less than 30% in 2023

$CONANT OPTICAL (02276.HK)$An announcement was issued. It is expected that the net profit attributable to shareholders of the Group for the year ended 31 December 2023 will increase by no less than 30% compared to the year ended 31 December 2022. The increase was mainly due to an increase in revenue due to an increase in the scale of the resin eyeglass lens business; an increase in gross profit due to an increase in product gross margin; a certain increase in exchange earnings due to the appreciation of the US dollar against the RMB; and a decrease in financial expenses due to a decrease in interest rates on interest-bearing bank loans and bank loans.

Earnings Report

$CONANT OPTICAL (02276.HK)$Yingxi: Net profit is expected to increase by no less than 30% in 2023

Operational data

$LI AUTO-W (02015.HK)$: A total of 31,165 new vehicles were delivered in January, an increase of 105.8% year-on-year

$GEELY AUTO (00175.HK)$Total car sales in January reached a record high of 213,500 units, up 110% year on year

$NIO-SW (09866.HK)$The delivery of 1,055 vehicles in January increased 18.2% year over year

$XPENG-W (09868.HK)$Delivery of 8,250 smart electric vehicles in January increased 58% year over year

$YUEXIUTRANSPORT (01052.HK)$: Humen Bridge toll revenue of 93.06 million yuan in December increased 61.7% year-on-year

Pharmaceutical Innovation

$LUYE PHARMA (02186.HK)$: LY03010 successfully challenged the patent in the US NDA review process

$JUNSHI BIO (01877.HK)$: The marketing license application for treprilimab was accepted by the Health Sciences Board of Singapore

$SINO BIOPHARM (01177.HK)$: “Obecholic Acid Tablets” submitted a marketing application and was accepted

$KINTOR PHARMA-B (09939.HK)$: Clinical trial of KX-826 combined with minoxidil to treat male AGA was approved by NMPA

$HENLIUS (02696.HK)$: Dexumab biosimilar drug HLX14 (recombinant anti-RANKL whole human monoclonal antibody injection) successfully completed phase 1 clinical study

Acquisition and sale

$KOWLOON DEV (00034.HK)$Proposed sale of 60% of Wei'an's share capital for HK$1.39 billion

$CH MODERN D (01117.HK)$Signed a share purchase agreement with Zhongken Fund Zhongken Fund to inject 600 million yuan into Hyundai Animal Husbandry (Wuhe) in cash

$CHINASOUTHCITY (01668.HK)$Proposed sale of approximately 30.6472% of Xi'an Huanan City shares (can be adjusted to 38.6988%)

Repurchase cancellation

$AIA (01299.HK)$2.4 million shares were repurchased at HK$147 million on February 1

$HSBC HOLDINGS (00005.HK)$On January 31, it spent HK$111 million to buy back 1.7972 million shares

$XIAOMI-W (01810.HK)$4 million shares were repurchased on February 1 at a cost of HK$49.93 million

$BEKE-W (02423.HK)$On January 31, it cost 5 million US dollars to buy back 1.048 million shares

$WANT WANT CHINA (00151.HK)$On February 1, it cost HK$16.25 million to repurchase 3.801 million shares

$COSCO SHIP HOLD (01919.HK)$On February 1, it cost HK$12.4036 million to repurchase 1.5 million shares

$ESR (01821.HK)$On February 1, it cost HK$9.987 million to repurchase 1 million shares

edit/new